Vaccine Stocks: The Beginning of the End?

Vaccine Stocks: The Beginning of the End?

The stock market started out the new week on a positive note, with sharp advances in major market benchmarks. The S&P 500 (SNPINDEX: ^GSPC) gained 61 points to 4,599, and the Nasdaq Composite (NASDAQINDEX: ^IXIC) rebounded 120 points to 15,206. Many investors now have to wonder: with their main growth driver seemingly starting to wind down, will vaccine stocks keep struggling going forward?